Skip to main content
BSE - SMEListed
Global Longlife Hospital and Research Limited Logo

Global Longlife Hospital and Research Limited IPO

Global Longlife Hospital and Research Limited IPO

IPO Date :
Issue Price :
Allotment Date :
Listing Date :
List Price :
Lot Size:
Subscription:
Listed Price: ₹ 141.10 (+0.79%)

Global Longlife Hospital and Research Limited's successfully completed its Initial Public Offering and commenced trading on 04-05-2022 at the BSE exchange. The company raised 35,00,000 Shares through this public offering, comprising 35,00,000 Shares in fresh capital.

The IPO was priced within the band of ₹140 to ₹140, with minimum application lots of 1000 shares. The offering attracted significant investor interest during its subscription period from 21-04-2022 to 25-04-2022.

Share allotment was finalized on 30-04-2022, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.

Global Longlife IPO Details
Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

IPO Reservation
Global Longlife IPO Key Performance Indicator
Company Financials ( In Lakhs )

Global Longlife IPO About Company

Global Longlife Hospital and Research Limited is an NABH-accredited multi-speciality tertiary care hospital based in Ahmedabad, Gujarat, offering a wide range of healthcare services including oncology, ophthalmology, cardiology, dermatology, gynecology, spine and plastic surgery, dialysis, physiotherapy, ultrasound, and microbiology. The hospital has a capacity of 110 well-equipped beds supporting both medical and surgical specialties, and as of December 31, 2021, it is supported by 11 full-time consultants, over 30 experienced consulting doctors, 37 nurses, and more than 50 paramedical, pharmacy, corporate, and support staff, ensuring comprehensive and quality patient care.


Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."


Global Longlife IPO Strength Factors

  1. Continuous Innovation: Regularly develops new and improved solutions.
  2. Technical Expertise: Strong technical skills and industry knowledge.

Global Longlife IPO Risk Factors

NA


Global Longlife IPO Lead Manager(s)

  • Interactive Financial Services Limited

Global Longlife IPO Promoter(s)

  1. Mr. Sureshkumar Babulal Jani
  2. Mr. Dhruv Sureshkumar Jani

Global Longlife IPO Company Details

Global Longlife Hospital and Research Limited
Phone:
address:

Global Longlife IPO Registrar

Bigshare Services Private Limited
Name:
Phone:

Global Longlife IPO FAQs